Popular Articles

Feb 11, 2018
Jin Zhang reviews the current fortunes of the Chinese pharmaceutical companies.
Feb 11, 2018
Pharmaceutical Executive
In this Q&A, Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally.
Jan 26, 2018
Pharmaceutical Executive
In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry landscape in 2018.
Jan 12, 2018
Pharmaceutical Executive
Bruno Strigini, CEO of Novartis Oncology, talks about the company’s pioneering path in cancer and the related broader issues such as pricing and value and new innovations in cancer science.
Aug 29, 2017
Pharmaceutical Executive
IFPMA's new Assistant Director General speaks about her mission to use the organization’s international reach to find real and practical solutions to the most pressing global healthcare challenges.
Aug 09, 2017
Pharmaceutical Executive
Pharm Exec’s 13th Annual Press Audit reveals a tonal undercurrent in sync with an industry unable to escape the glare of scrutiny.
Jul 13, 2017
Pharmaceutical Executive
Digital interventions in drug adherence regimes are evolving to new levels of sophistication, but patient-behavior and privacy issues still present significant challenges.
Jul 12, 2017
Pharmaceutical Executive
The industry’s potential in tapping digital health to transform patient care hinges on new shifts in culture and business strategy. Michelle Maskaly reports.
Jul 01, 2017
Pharmaceutical Executive
With healthcare professionals and patients now collecting much of their information online, there is new opportunity for “digital opinion influencers” to amplify traditional KOL messaging—or create their own.
Jun 28, 2017
Pharmaceutical Executive
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
native1_300x100
lorem ipsum